Utah Medical Products (UTMD)
NASDAQ:UTMD
Total Valuation
Utah Medical Products has a market cap or net worth of $205.53M. The enterprise value is $121.20M.
Market Cap$205.53M
Enterprise Value$121.20M
Share Statistics
Utah Medical Products has 3,185,025 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,185,025
Owned by Insiders0.69%
Owned by Institutions22.51%
Financial Efficiency
Utah Medical Products’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 7.60%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)7.60%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee248.52K
Profits Per Employee72.81K
Employee Count155
Asset Turnover0.31
Inventory Turnover2.35
Valuation Ratios
The current PE Ratio of Utah Medical Products is 16.4. Utah Medical Products’s PEG ratio is -1.18.
PE Ratio16.4
PS Ratio4.81
PB Ratio1.55
Price to Fair Value1.55
Price to FCF12.93
Price to Operating Cash Flow14.30
PEG Ratio-1.18
Income Statement
In the last 12 months, Utah Medical Products had revenue of 38.52M and earned 11.29M in profits. Earnings per share was 3.41.
Revenue38.52M
Gross Profit19.88M
Operating Income11.40M
Pretax Income14.11M
Net Income11.29M
EBITDA17.06M
Earnings Per Share (EPS)3.41
Cash Flow
In the last 12 months, operating cash flow was 14.69M and capital expenditures -371.00K, giving a free cash flow of 14.32M billion.
Operating Cash Flow14.69M
Free Cash Flow14.32M
Free Cash Flow per Share4.50
Dividends & Yields
Utah Medical Products pays an annual dividend of $0.31, resulting in a dividend yield of 2.15%
Dividend Per Share$0.31
Dividend Yield2.15%
Payout Ratio34.65%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change20.20%
50-Day Moving Average63.86
200-Day Moving Average59.42
Relative Strength Index (RSI)53.94
Average Volume (3m)15.88K
Important Dates
Utah Medical Products upcoming earnings date is Apr 28, 2026, TBA (Confirmed).
Last Earnings DateJan 29, 2026
Next Earnings DateApr 28, 2026
Ex-Dividend Date―
Financial Position
Utah Medical Products as a current ratio of 37.62, with Debt / Equity ratio of 0.19%
Current Ratio37.62
Quick Ratio34.57
Debt to Market Cap0.00
Net Debt to EBITDA-5.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Utah Medical Products has paid 2.82M in taxes.
Income Tax2.82M
Effective Tax Rate0.20
Enterprise Valuation
Utah Medical Products EV to EBITDA ratio is 5.84, with an EV/FCF ratio of 6.96.
EV to Sales2.59
EV to EBITDA5.84
EV to Free Cash Flow6.96
EV to Operating Cash Flow6.79
Balance Sheet
Utah Medical Products has $85.76M in cash and marketable securities with $225.00K in debt, giving a net cash position of $85.53M billion.
Cash & Marketable Securities$85.76M
Total Debt$225.00K
Net Cash$85.53M
Net Cash Per Share$26.85
Tangible Book Value Per Share$31.53
Margins
Gross margin is 52.92%, with operating margin of 29.60%, and net profit margin of 29.30%.
Gross Margin52.92%
Operating Margin29.60%
Pretax Margin36.63%
Net Profit Margin29.30%
EBITDA Margin44.29%
EBIT Margin36.63%
Analyst Forecast
The average price target for Utah Medical Products is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-12.35%
EPS Growth Forecast-17.20%